Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H12O2 |
| Molecular Weight | 164.2011 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)CCC1=CC=C(O)C=C1
InChI
InChIKey=NJGBTKGETPDVIK-UHFFFAOYSA-N
InChI=1S/C10H12O2/c1-8(11)2-3-9-4-6-10(12)7-5-9/h4-7,12H,2-3H2,1H3
| Molecular Formula | C10H12O2 |
| Molecular Weight | 164.2011 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Raspberry ketone (4-(4-hydroxyphenyl) butan-2-one; RK) is a major aromatic compound of red raspberry (Rubus idaeus) and is marketed on the Internet as a food supplement. The FDA classified it as GRAS (Generally Recognized as safe) food additives during the 1960s. The structure of RK is similar to the structures of capsaicin and synephrine, compounds known to exert anti-obese actions and alter the lipid metabolism. It was shown, that RK also decreased the weights and hepatic triacylglycerol content in rodents after they had been increased by a high-fat diet. Recently was discovered, that RK may exert anti-adipogenic effects through modulation of the HO-1/Wnt/beta-catenin signaling pathway. Investigations of raspberry ketone in quantitative structure-activity relationship (QSAR) models indicated potential cardiotoxic effects and potential effects on reproduction/development. Taking into account the high intake via supplements, the compound's toxic potential should be clarified with further experimental studies. In UK the pure compound is regarded as novel food requiring authorisation prior to marketing but raspberry ketone is not withdrawn from Internet sites from this country.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: HO-1/Wnt/beta-catenin signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/28606512 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| The mouse eugenol odorant receptor: structural and functional plasticity of a broadly tuned odorant binding pocket. | 2011-02-08 |
|
| Effect of essential oils, such as raspberry ketone and its derivatives, on antiandrogenic activity based on in vitro reporter gene assay. | 2010-04-01 |
|
| Evaluation of skin diseases and disorders in photographers. | 2009-08 |
|
| Phenols from the roots of Rheum palmatum attenuate chemotaxis in rat hepatic stellate cells. | 2008-08 |
|
| Characterization of headspace aroma compounds of freshly brewed arabica coffees and studies on a characteristic aroma compound of Ethiopian coffee. | 2008-06 |
|
| Analysis of the headspace volatiles of freshly brewed arabica coffee using solid-phase microextraction. | 2007-09 |
|
| Microbial production of 4-hydroxybenzylidene acetone, the direct precursor of raspberry ketone. | 2007-07 |
|
| Aroma extract dilution analysis of cv. Meeker (Rubus idaeus L.) red raspberries from Oregon and Washington. | 2004-08-11 |
|
| Raspberry ketone from submerged cultured cells of the basidiomycete Nidula niveo-tomentosa. | 2001-06-02 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rightshape.com/raspberry-ketone/
The recommended dosage of Raspberry Ketone to take is 100 mg, taken once per day, especially for first time users of the supplement. However, is possible to intake to about 2 or 3 100 mg capsule of the supplement per day.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20425690
To elucidate a possible mechanism for the antiobesity action of Raspberry ketone (4-(p-hydroxyphenyl)-2-butanone/RK), its effects on the expression and the secretion of adiponectin, lipolysis, and fatty acid oxidation in 3T3-L1 were investigated. Treatment with 10 µM of RK increased lipolysis significantly in differentiated 3T3-L1 cells. An immunoassay showed that RK increased both the expression and the secretion of adiponectin, an adipocytokine mainly expressed and secreted by adipose tissue. In addition, treatment with 10 µM of RK increased the fatty acid oxidation and suppressed lipid accumulation in 3T3-L1 adipocytes.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:37:32 GMT 2025
by
admin
on
Mon Mar 31 18:37:32 GMT 2025
|
| Record UNII |
7QY1MH15BG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
||
|
JECFA EVALUATION |
4-(P-HYDROXYPHENYL)-2-BUTANONE
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
||
|
DSLD |
3353 (Number of products:284)
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB61972
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
21648
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
m11999
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
226-806-4
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
7QY1MH15BG
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
1860422
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
1598813
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
SUB63774
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
8163
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
26515
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
RASPBERRY KETONE
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
100000134384
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
7QY1MH15BG
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
68656
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
DTXSID5044495
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
5471-51-2
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY | |||
|
601
Created by
admin on Mon Mar 31 18:37:32 GMT 2025 , Edited by admin on Mon Mar 31 18:37:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |